[Federal Register Volume 66, Number 143 (Wednesday, July 25, 2001)]
[Notices]
[Pages 38713-38714]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 01-18478]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration


Anesthetic and Life Support Drugs Advisory Committee; Notice of 
Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice.

-----------------------------------------------------------------------

[[Page 38714]]

    This notice announces a forthcoming meeting of a public advisory 
committee of the Food and Drug Administration (FDA). The meeting will 
be open to the public.
    Name of Committee: Anesthetic and Life Support Drugs Advisory 
Committee.
    General Function of the Committee: To provide advice and 
recommendations to the agency on FDA's regulatory issues.
    Date and Time: The meeting will be held on September 13 and 14, 
2001, from 8 a.m. to 5 p.m.
    Location: University of Maryland, Shady Grove Campus, multi-purpose 
room, Bldg. 9630, Gudelsky Dr., Rockville, MD.
    Contact: Kimberly Littleton Topper, Center for Drug Evaluation and 
Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for 
express delivery, 5630 Fishers Lane, rm. 1091), Rockville, MD 20857, 
301-827-7001, or FDA Advisory Committee Information Line, 1-800-741-
8138 (301-443-0572 in the Washington, DC area), code 12529. Please call 
the Information Line for up-to-date information on this meeting.
    Agenda: On both days, the committee will discuss the medical use of 
opiate analgesics in various patient populations, including pediatric 
patients and patients with chronic pain of nonmalignant etiology, as 
well as the risk to benefit ratio of extending opiate treatment into 
these populations. It will also address concerns regarding the abuse 
potential, diversion and increasing incidence of addiction to opiate 
analgesics, especially to the modified release opiate analgesics.
    Procedure: Interested persons may present data, information, or 
views, orally or in writing, on issues pending before the committee. 
Written submissions may be made to the contact person by August 17, 
2001. Oral presentations from the public will be scheduled between 
approximately 1 p.m. and 2 p.m. on September 13, 2001, and between 
approximately 9 a.m. and 10 a.m. on September 14, 2001. Time allotted 
for each presentation may be limited. Those desiring to make formal 
oral presentations should notify the contact person before August 17, 
2001, and submit a brief statement of the general nature of the 
evidence or arguments they wish to present, the names and addresses of 
proposed participants, and an indication of the approximate time 
requested to make their presentation.
    Notice of this meeting is given under the Federal Advisory 
Committee Act (5 U.S.C. app. 2).

    Dated: July 19, 2001.
Linda A. Suydam,
Senior Associate Commissioner.
[FR Doc. 01-18478 Filed 7-24-01; 8:45 am]
BILLING CODE 4160-01-S